Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005059
Filing Date
2021-11-03
Accepted
2021-11-03 19:54:22
Documents
1
Period of Report
2021-11-03

Document Format Files

Seq Description Document Type Size
1 form4-11032021_041112.html 4  
1 form4-11032021_041112.xml 4 5004
  Complete submission text file 0001415889-21-005059.txt   6354
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Reporting) CIK: 0001728916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 211377384